Clinical Trials Directory

Trials / Completed

CompletedNCT05019222

Comparison of Postoperative QoR-15 Scores Between Sevoflurane and Remimazolam

Comparison of Quality of Recovery (QoR)-15 Scores According to the Use of Anesthetics During General Anesthesia in the Cervical Spine Surgery Patients: Sevoflurane vs. Remimazolam

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Gangnam Severance Hospital · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to compare the quality of recovery (QoR)-15 scores according to the use of maintenance anesthetics in the cervical spine surgery. Total intravenous anesthesia (TIVA) have been known to help reducing risks of postoperative nausea/vomiting and malignant hyperthermia. However, it is still not enough to explain which is better between TIVA or inhalation anesthesia. In particular, there is no study to investigate overall postoperative functional recovery via QoR-15 in patients receiving TIVA with remimazolam. The hypothesis of the investigators study is that, in patients with cervical spine surgery, total intravenous anesthesia based on remimazolam can improve the the quality of recovery compared to inhalation anesthesia based on sevoflurane.

Conditions

Interventions

TypeNameDescription
DRUGSevoflurane based inhalation anesthesiaSevoflurane group will be inducted with bolus of propofol 1% and maintained with sevofulrane as inhalation and TCI Minto model of remifentanil for general anesthesia.
DRUGRemimazolam based total intravenous anesthesiaRemimazolam group will be inducted with remiamazolam at 6 mg/kg/h and maintained with remimazolam at 0.5-1.5 mg/kg/h and TCI Minto model of remifentanil for general anesthesia.

Timeline

Start date
2021-09-26
Primary completion
2022-08-14
Completion
2022-08-14
First posted
2021-08-24
Last updated
2023-04-25

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05019222. Inclusion in this directory is not an endorsement.